4 surgeons general call for annual cognitive assessments
By
Lois A. Bowers
Oct 14, 2019
Four former U.S. surgeons general are advocating for regular annual cognitive assessments as part of routine check-ups, calling dementia the No. 1 public health crisis.
Clinton shares Alzheimer’s plans
By
Lois A. Bowers
Dec 22, 2015
Democratic presidential candidate Hillary Clinton unveiled a plan Dec. 22 to invest $2 billion per year to prevent, treat and make possible a cure for Alzheimer’s disease by the year 2025 if she...
Are you ready for an Alzheimer’s breakthrough?
By
Lois A. Bowers
Nov 20, 2017
Some treatments for Alzheimer’s may be available by 2020. If so, the U.S. healthcare system may not be prepared, according to a new study.
Legislation with $425 million increase for Alzheimer’s headed to president’s desk
By
Lois A. Bowers
Sep 27, 2018
An appropriations “minibus” funding bill that includes a $425 million increase for Alzheimer’s and dementia research funding at the National Institutes of Health is headed for the White House after...
Alzheimer’s brain effects can differ between racial groups
By
Lois A. Bowers
Jul 16, 2015
Alzheimer’s disease may cause different changes in the brain in African-Americans than in white Americans of European descent, according to new study.
5 lessons we’ve learned by not segregating memory care residents
By
Vassar Byrd
Feb 03, 2020
The benefits of not offering memory care in a separate, locked unit far outweigh the effort needed — and we’ve learned some lessons along the way.
Interventions for Alzheimer’s disease improve cognition in men, women
May 03, 2022
Individualized multidomain interventions are equally effective for improving cognition in women and men.
Virtual reality helps diagnose Alzheimer’s disease earlier, study finds
By
Lois A. Bowers
May 28, 2019
Virtual reality can identify early Alzheimer’s disease more accurately than cognitive tests currently considered to be the “gold standard,” suggests a new study published in the journal Brain.
Two Alzheimer’s drug trials halted
By
Lois A. Bowers
Mar 22, 2019
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.
Computerized approach detects Alzheimer’s with 82% accuracy
By
Lois A. Bowers
Jan 13, 2016
Researchers have discovered how speech impairments can help diagnose Alzheimer’s disease with more than 82% accuracy and have developed automated technology to detect the impairments.